Unknown

Dataset Information

0

Silicone Breast Implant Coated with Triamcinolone Inhibited Breast-Implant-Induced Fibrosis in a Porcine Model.


ABSTRACT: Cosmetic silicone implants for breast reconstruction often lead to medical complications, such as abnormally excessive fibrosis driven by foreign body granulomatous inflammation. The purpose of this study was to develop a silicone breast implant capable of local and controlled release of a glucocorticoid drug triamcinolone acetonide (TA) for the prevention of silicone-breast-implant-induced fibrosis in a Yorkshire pig model (in vivo). Implants were dip-coated in a TA solution to load 1.85 μg/cm2 of TA in the implant shell, which could release the drug in a sustained manner for over 50 days. Immunohistochemical analysis for 12 weeks showed a decline in tumor necrosis factor-α expression, capsule thickness, and collagen density by 82.2%, 55.2%, and 32.3%, respectively. Furthermore, the counts of fibroblasts, macrophages, and myofibroblasts in the TA-coated implants were drastically reduced by 57.78%, 48.8%, and 64.02%, respectively. The TA-coated implants also lowered the expression of vimentin and α-smooth muscle actin proteins, the major profibrotic fibroblast and myofibroblast markers, respectively. Our findings suggest that TA-coated silicone breast implants can be a promising strategy for safely preventing fibrosis around the implants.

SUBMITTER: Nam SY 

PROVIDER: S-EPMC8307199 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6419080 | biostudies-literature
| S-EPMC7319285 | biostudies-literature
| S-EPMC7396908 | biostudies-literature
| S-EPMC6153863 | biostudies-other
| S-EPMC10985323 | biostudies-literature
| S-EPMC11250684 | biostudies-literature
| S-EPMC10969816 | biostudies-literature
| S-EPMC6611608 | biostudies-literature
2011-09-29 | E-GEOD-29768 | biostudies-arrayexpress
| S-EPMC5751029 | biostudies-literature